Diagnostic Lab Testing Transparency Act

12/20/2024, 9:05 AM

Diagnostic Lab Testing Transparency Act

This bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.

Specifically, providers must post and annually update information about the discounted cash price and the minimum and maximum negotiated rates of each test, including ancillary services. The Centers for Medicare & Medicaid Services may assess civil penalties for violations.

The Diagnostic Lab Testing Transparency Act, also known as Bill 118 hr 3248, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to increase transparency and accountability in the diagnostic lab testing industry.

One of the key provisions of the bill is the requirement for diagnostic lab testing facilities to disclose the prices of their services to patients before they undergo any testing. This is aimed at helping patients make more informed decisions about their healthcare and avoid surprise billing.

Additionally, the bill includes measures to prevent overcharging by diagnostic lab testing facilities. It requires these facilities to provide itemized bills to patients, detailing the cost of each test and service provided. This will help ensure that patients are not being charged excessively for their diagnostic testing. Furthermore, the Diagnostic Lab Testing Transparency Act includes provisions to improve the quality of diagnostic lab testing services. It requires facilities to adhere to certain quality standards and guidelines set forth by the Department of Health and Human Services. This will help ensure that patients receive accurate and reliable test results. Overall, the Diagnostic Lab Testing Transparency Act aims to promote transparency, accountability, and quality in the diagnostic lab testing industry. By requiring facilities to disclose prices, prevent overcharging, and adhere to quality standards, this bill seeks to protect patients and improve the overall healthcare system.
Congress
118

Number
HR - 3248

Introduced on
2023-05-11

# Amendments
0

Sponsors
+5

Cosponsors
+5

Variations and Revisions

5/11/2023

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Diagnostic Lab Testing Transparency Act

This bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.

Specifically, providers must post and annually update information about the discounted cash price and the minimum and maximum negotiated rates of each test, including ancillary services. The Centers for Medicare & Medicaid Services may assess civil penalties for violations.

The Diagnostic Lab Testing Transparency Act, also known as Bill 118 hr 3248, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to increase transparency and accountability in the diagnostic lab testing industry.

One of the key provisions of the bill is the requirement for diagnostic lab testing facilities to disclose the prices of their services to patients before they undergo any testing. This is aimed at helping patients make more informed decisions about their healthcare and avoid surprise billing.

Additionally, the bill includes measures to prevent overcharging by diagnostic lab testing facilities. It requires these facilities to provide itemized bills to patients, detailing the cost of each test and service provided. This will help ensure that patients are not being charged excessively for their diagnostic testing. Furthermore, the Diagnostic Lab Testing Transparency Act includes provisions to improve the quality of diagnostic lab testing services. It requires facilities to adhere to certain quality standards and guidelines set forth by the Department of Health and Human Services. This will help ensure that patients receive accurate and reliable test results. Overall, the Diagnostic Lab Testing Transparency Act aims to promote transparency, accountability, and quality in the diagnostic lab testing industry. By requiring facilities to disclose prices, prevent overcharging, and adhere to quality standards, this bill seeks to protect patients and improve the overall healthcare system.
Alternative Names
Official Title as IntroducedTo amend title XVIII of the Social Security Act to increase price transparency of clinical diagnostic laboratory tests under the Medicare program.

Policy Areas
Health

Potential Impact
Civil actions and liability
Health care costs and insurance
Medical tests and diagnostic methods

Comments

Recent Activity

Latest Summary1/12/2024

Diagnostic Lab Testing Transparency Act

This bill requires providers of clinical diagnostic laboratory tests under Medicare to publicly post certain information relating to the prices of services.

Specifically, providers must...


Latest Action12/17/2024
Referred to the Subcommittee on Health.